Down syndrome and type I interferon: not so simple.


Journal

Current opinion in immunology
ISSN: 1879-0372
Titre abrégé: Curr Opin Immunol
Pays: England
ID NLM: 8900118

Informations de publication

Date de publication:
10 2021
Historique:
received: 14 04 2021
revised: 02 06 2021
accepted: 08 06 2021
pubmed: 27 6 2021
medline: 11 3 2022
entrez: 26 6 2021
Statut: ppublish

Résumé

Down syndrome (DS) is characterized by a collection of clinical features including intellectual disability, congenital malformations, and susceptibility to infections and autoimmune diseases. While the presence of an extra chromosome 21 is known to cause DS, the precise genetic annotation linked to specific clinical features is largely missing. However, there is growing evidence that two genes located on chromosome 21, IFNAR1 and IFNAR2, play an important role in disease pathogenesis. These genes encode the two subunits of the receptor for type I interferons (IFN-I), a group of potent antiviral and pro-inflammatory cytokines. Human monogenic diseases caused by uncontrolled IFN-I production and response have been well characterized, and they clinically overlap with DS but also have notable differences. Herein, we review the literature characterizing the role of IFN-I in DS and compare and contrast DS to other IFN-mediated conditions. The existing IFN-I literature serves as a rich resource for testable hypotheses to elucidate disease mechanisms in DS and is likely to open novel therapeutic avenues.

Identifiants

pubmed: 34174697
pii: S0952-7915(21)00076-5
doi: 10.1016/j.coi.2021.06.006
pmc: PMC8578175
mid: NIHMS1715264
pii:
doi:

Substances chimiques

Biomarkers 0
Interferon Type I 0
Receptors, Interferon 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

196-205

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI150300
Pays : United States
Organisme : NICHD NIH HHS
ID : T32 HD075735
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Références

Proc Natl Acad Sci U S A. 2019 Nov 26;116(48):24231-24241
pubmed: 31699819
Clin Exp Dermatol. 2006 Sep;31(5):623-9
pubmed: 16901300
Blood. 2015 Jan 22;125(4):591-9
pubmed: 25359994
Nat Rev Immunol. 2018 Sep;18(9):545-558
pubmed: 29921905
Elife. 2016 Jul 29;5:
pubmed: 27472900
Ann Intern Med. 2021 Apr;174(4):572-576
pubmed: 33085509
J Glob Health. 2017 Dec;7(2):020413
pubmed: 29302319
J Clin Invest. 2021 Jan 4;131(1):
pubmed: 33393505
Nat Rev Genet. 2017 Mar;18(3):147-163
pubmed: 28029161
Immunity. 2018 Sep 18;49(3):397-412
pubmed: 30231982
J Clin Immunol. 2020 Aug;40(6):807-819
pubmed: 32572726
J Clin Invest. 2019 Jul 29;129(9):3625-3639
pubmed: 31355779
Rheumatology (Oxford). 2019 Feb 1;58(Suppl 1):i4-i16
pubmed: 30806710
Ann Neurol. 2020 Jul;88(1):137-147
pubmed: 32320094
Immunol Rev. 2012 Nov;250(1):317-34
pubmed: 23046138
Front Immunol. 2020 May 08;11:840
pubmed: 32457756
Prenat Diagn. 2006 Jun;26(6):499-504
pubmed: 16634111
Science. 1974 Oct 4;186(4158):61-3
pubmed: 4371269
Cell Host Microbe. 2016 Feb 10;19(2):181-93
pubmed: 26867177
Sci Rep. 2017 Nov 1;7(1):14818
pubmed: 29093484
Genet Med. 2021 Mar;23(3):576-580
pubmed: 33060835
BMJ Case Rep. 2021 Apr 23;14(4):
pubmed: 33893139
J Biol Chem. 2017 May 5;292(18):7285-7294
pubmed: 28289098
Proc Natl Acad Sci U S A. 2021 Feb 9;118(6):
pubmed: 33526671
Science. 1986 Oct 17;234(4774):355-8
pubmed: 2429366
Front Physiol. 2018 Jun 08;9:686
pubmed: 29937734
Neuroradiology. 1984;26(6):493-8
pubmed: 6239108
Nat Rev Immunol. 2012 Jan 06;12(2):125-35
pubmed: 22222875
J Clin Immunol. 2020 Aug;40(6):791-806
pubmed: 32638194
Ann N Y Acad Sci. 1982;396:179-89
pubmed: 6185033
Cell Rep. 2019 Nov 12;29(7):1893-1908.e4
pubmed: 31722205
Annu Rev Med. 2017 Jan 14;68:297-315
pubmed: 27813875
Emerg Infect Dis. 2010 Aug;16(8):1312-4
pubmed: 20678334
Pediatr Rheumatol Online J. 2016 Jun 04;14(1):35
pubmed: 27260006
Front Immunol. 2020 Mar 18;11:475
pubmed: 32256502
Immunol Cell Biol. 2012 May;90(5):483-91
pubmed: 22410872
JAAD Case Rep. 2019 Apr 05;5(4):365-367
pubmed: 31008170
Pediatr Infect Dis J. 2020 Aug;39(8):665-670
pubmed: 32332221
N Engl J Med. 2020 Jun 11;382(24):2344-2352
pubmed: 32521135
Virol J. 2011 Jul 18;8:354
pubmed: 21762537
Pediatr Blood Cancer. 2012 Dec 15;59(7):1310-2
pubmed: 22811045
Teratology. 1995 May;51(5):329-35
pubmed: 7482354
Nat Rev Dis Primers. 2020 Feb 6;6(1):9
pubmed: 32029743
Science. 2020 Oct 23;370(6515):
pubmed: 32972996
Arthritis Rheumatol. 2016 Jul;68(7):1688-99
pubmed: 26866723
Cell Rep. 2020 Nov 17;33(7):108407
pubmed: 33207208
Front Immunol. 2018 Nov 20;9:2683
pubmed: 30515165
Ann Neurol. 2021 Jul;90(1):4-14
pubmed: 33547827
Clin Exp Immunol. 2011 Apr;164(1):9-16
pubmed: 21352207
J Interferon Cytokine Res. 2000 Feb;20(2):197-203
pubmed: 10714556
J Neural Transm (Vienna). 2012 Feb;119(2):197-209
pubmed: 21744051
Nat Commun. 2019 Oct 18;10(1):4766
pubmed: 31628327
Genet Med. 2017 Apr;19(4):439-447
pubmed: 27608174
Oncotarget. 2017 Sep 19;8(48):84489-84496
pubmed: 29137441
Nat Commun. 2016 May 19;7:11496
pubmed: 27193971
Mol Cell Biol. 2009 Sep;29(17):4778-87
pubmed: 19564411
J Immunol. 2018 Dec 15;201(12):3479-3485
pubmed: 30530500
Brain Res. 1999 Jul 17;835(1):46-61
pubmed: 10448195
J Exp Med. 2016 Nov 14;213(12):2527-2538
pubmed: 27821552
Nat Commun. 2019 Oct 3;10(1):4495
pubmed: 31582743
Science. 2019 Jul 12;365(6449):176-180
pubmed: 31296770
Pediatr Dermatol. 2020 Nov;37(6):1044-1050
pubmed: 32892406
Ment Retard. 1995 Feb;33(1):54-6
pubmed: 7707939
Rheumatology (Oxford). 2021 Sep 1;60(9):e309-e311
pubmed: 33630031
J Exp Med. 2016 Jun 27;213(7):1163-74
pubmed: 27325888
PLoS One. 2018 Mar 27;13(3):e0194581
pubmed: 29584757
Am J Med Genet. 1999 Jun 11;84(5):406-12
pubmed: 10360394
Placenta. 2020 Jan 1;89:58-66
pubmed: 31683073
Ann N Y Acad Sci. 1980;350:12-20
pubmed: 6165266
Birth Defects Res. 2019 Nov 1;111(18):1420-1435
pubmed: 31580536
Cell Mol Neurobiol. 2018 Apr;38(3):769-774
pubmed: 28687876
J Neurol Neurosurg Psychiatry. 1985 Jan;48(1):61-4
pubmed: 3156213
Science. 2012 Sep 28;337(6102):1684-8
pubmed: 22859821
Annu Rev Pathol. 2019 Jan 24;14:369-393
pubmed: 30332560
Int J Immunopathol Pharmacol. 2005 Jan-Mar;18(1):165-72
pubmed: 15698521
Nat Commun. 2016 Dec 05;7:13476
pubmed: 27917878
Proc Natl Acad Sci U S A. 2020 Jul 28;117(30):17510-17512
pubmed: 32665439
PLoS One. 2012;7(10):e46082
pubmed: 23091595
Dev Med Child Neurol. 1991 Mar;33(3):191-200
pubmed: 1827417

Auteurs

Louise Malle (L)

Center for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Dusan Bogunovic (D)

Center for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: dusan.bogunovic@mssm.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH